Immuron (Warrant)

YTD

ALL

Why Robinhood?

You can watch IMRNW and buy or sell other stocks, ETFs, and their options commission-free!

About IMRNW

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments.

CEO

Steven Lydeamore, MBA

CEOSteven Lydeamore, MBA

Employees

—

Employees—

Headquarters

Blackburn, Victoria (VIC)

HeadquartersBlackburn, Victoria (VIC)

Founded

1994

Founded1994

Employees

—

Employees—

IMRNW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

IMRNW News

TipRanks 4d

Immuron Calls November AGM to Decide Board Seats, Incentive Plan and Capital-Raising Capacity

The latest announcement is out from Immuron ( (IMRN) ). Immuron Limited, an Australia-based biotechnology company dual-listed on the ASX and Nasdaq, develops i...

TipRanks 7d

Immuron’s Travelan Phase 2 study results published

Immuron (IMRN) announced that data from its Phase 2 clinical trial of once-daily oral Travelan has been published in the Nature Journal, Scientific Reports. The...

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.